SUMMARY: Gradient-echo (GE) imaging is recognized as a means to detect hemorrhagic changes in cerebral amyloid angiopathy (CAA). However, almost 25 % of patients with CAA do not show micro-hemorrhages on T2 * GE imaging. We applied a new imaging method, susceptibility weighted imaging (SWI), to evaluate the presence of microhemorrhages. In a suspected case of CAA, where cognitive effects are also present, we show that SWI is much more sensitive in detecting microhemorrhages than conventional methods. Susceptibility-weighted imaging (SWI) is a new imagingmethod that maximizes sensitivity to magnetic suscepti-bility effects1,2 and is clinically useful for evaluating trauma and vascular malformations.3,4 However, the role of SWI in other neuro...
none11siBackground and purpose: Cerebral microbleeds (MB) and superficial siderosis (SS) are frequen...
<div><p>Background</p><p>We sought to summarize Computed Tomography (CT)/Magnetic Resonance Imaging ...
AbstractAn 88-year-old woman with a clinical diagnosis of Alzheimer's disease and advanced dementia,...
Cerebral amyloid angiopathy (CAA) is a cerebral small vessel disease caused by β -amyloid (Aβ) depos...
Background: Intracerebral hemorrhage and cognitive decline are typical clinical presentations of cer...
BACKGROUND AND PURPOSE: The emergence of cerebral microbleeds (CMB) as commonMR imaging findings rai...
Cerebral amyloid angiopathy (CAA) is an important cause of lobar intracerebral haemorrhage (ICH) in ...
Objective: We investigated whether severe, MRI-visible perivascular spaces (PVS) in the cerebral hem...
BACKGROUND AND AIM: To investigate whether a striped occipital cortex and intragyral hemorrhage, two...
Contains fulltext : 220659.pdf (Publisher’s version ) (Closed access)Small subclin...
BACKGROUND Cerebral amyloid angiopathy (CAA), a common cause of intracerebral hemorrhage (ICH), i...
International audienceBackground and Purpose: The in vivo diagnosis of cerebral amyloid angiopathy (...
Cerebral amyloid angiopathy (CAA) is characterized by the accumulation of amyloid beta-peptides (Ab)...
Background: Pathological changes in the cerebral white matter can be determined both in small vessel...
Cerebral amyloid angiopathy is a common neuropathological finding in the ageing human brain, associa...
none11siBackground and purpose: Cerebral microbleeds (MB) and superficial siderosis (SS) are frequen...
<div><p>Background</p><p>We sought to summarize Computed Tomography (CT)/Magnetic Resonance Imaging ...
AbstractAn 88-year-old woman with a clinical diagnosis of Alzheimer's disease and advanced dementia,...
Cerebral amyloid angiopathy (CAA) is a cerebral small vessel disease caused by β -amyloid (Aβ) depos...
Background: Intracerebral hemorrhage and cognitive decline are typical clinical presentations of cer...
BACKGROUND AND PURPOSE: The emergence of cerebral microbleeds (CMB) as commonMR imaging findings rai...
Cerebral amyloid angiopathy (CAA) is an important cause of lobar intracerebral haemorrhage (ICH) in ...
Objective: We investigated whether severe, MRI-visible perivascular spaces (PVS) in the cerebral hem...
BACKGROUND AND AIM: To investigate whether a striped occipital cortex and intragyral hemorrhage, two...
Contains fulltext : 220659.pdf (Publisher’s version ) (Closed access)Small subclin...
BACKGROUND Cerebral amyloid angiopathy (CAA), a common cause of intracerebral hemorrhage (ICH), i...
International audienceBackground and Purpose: The in vivo diagnosis of cerebral amyloid angiopathy (...
Cerebral amyloid angiopathy (CAA) is characterized by the accumulation of amyloid beta-peptides (Ab)...
Background: Pathological changes in the cerebral white matter can be determined both in small vessel...
Cerebral amyloid angiopathy is a common neuropathological finding in the ageing human brain, associa...
none11siBackground and purpose: Cerebral microbleeds (MB) and superficial siderosis (SS) are frequen...
<div><p>Background</p><p>We sought to summarize Computed Tomography (CT)/Magnetic Resonance Imaging ...
AbstractAn 88-year-old woman with a clinical diagnosis of Alzheimer's disease and advanced dementia,...